Commentary on: "Comprehensive transcriptional analysis of early-stage urothelial carcinoma." Hedegaard J, Lamy P, Nordentoft I, Algaba F, Høyer S, Ulhøi BP, Vang S, Reinert T, Hermann GG, Mogensen K, Thomsen MB, Nielsen MM, Marquez M, Segersten U, Aine M, Höglund M, Birkenkamp-Demtröder K, Fristrup N, Borre M, Hartmann A, Stöhr R, Wach S, Keck B, Seitz AK, Nawroth R, Maurer T, Tulic C, Simic T, Junker K, Horstmann M, Harving N, Petersen AC, Calle ML, Steyerberg EW, Beukers W, van Kessel KE, Jensen JB, Pedersen JS, Malmström PU, Malats N, Real FX, Zwarthoff EC, Ørntoft TF, Dyrskjøt L. Cancer Cell. 2016 Jul 11;30(1):27-42.

Autor: Lee BH

Publikováno v: Urologic oncology [Urol Oncol] 2017 Sep; Vol. 35 (9), pp. 576-577. Date of Electronic Publication: 2017 Aug 05.

Raman Spectroscopy for Instant Bladder Tumor Diagnosis: System Development and In Vivo Proof-Of-Principle Study in Accordance with the European Medical Device Regulation (MDR2017/745).

Autor: Latka I; Leibniz-Institute of Photonic Technology (IPHT), Leibniz-Health-Technologies, Leibniz-Center for Photonics in Infection Research (LPI), Albert-Einstein-Str. 9, 07745 Jena, Germany., Mogensen K; Urology Department Herlev, Gentofte Hospital, Borgmester Ib Juuls vej 23A, DK-2730 Herlev/Copenhagen, Denmark., Knorr F; Leibniz-Institute of Photonic Technology (IPHT), Leibniz-Health-Technologies, Leibniz-Center for Photonics in Infection Research (LPI), Albert-Einstein-Str. 9, 07745 Jena, Germany., Kuzucu C; 2M Engineering, John F Kennedylaan 3, 5555XC Valkenswaard, The Netherlands., Windirsch F; Leibniz-Institute of Photonic Technology (IPHT), Leibniz-Health-Technologies, Leibniz-Center for Photonics in Infection Research (LPI), Albert-Einstein-Str. 9, 07745 Jena, Germany., Sandic D; Blazejewski MEDI-TECH GmbH, Rheinstr. 1, 793650 Freiburg, Germany., Popp J; Leibniz-Institute of Photonic Technology (IPHT), Leibniz-Health-Technologies, Leibniz-Center for Photonics in Infection Research (LPI), Albert-Einstein-Str. 9, 07745 Jena, Germany.; Institute of Physical Chemistry (IPC) and Abbe Center of Photonics (ACP), Leibniz Center for Photonics in Infection Research (LPI), Friedrich-Schiller-University Jena, Helmholtzweg 4, 07743 Jena, Germany., Hermann GG; Urology Department Herlev, Gentofte Hospital, Borgmester Ib Juuls vej 23A, DK-2730 Herlev/Copenhagen, Denmark., Schie IW; Leibniz-Institute of Photonic Technology (IPHT), Leibniz-Health-Technologies, Leibniz-Center for Photonics in Infection Research (LPI), Albert-Einstein-Str. 9, 07745 Jena, Germany.; Department of Medical Engineering and Biotechnology, University of Applied Sciences Jena, Carl-Zeiss-Promenade 2, 07745 Jena, Germany.

Publikováno v: Cancers [Cancers (Basel)] 2024 Sep 23; Vol. 16 (18). Date of Electronic Publication: 2024 Sep 23.

Reply to Deng-Xiong Li, De-Chao Feng, and Shi Deng's Letter to the Editor re: Gyrithe Lynghøj Pedersen, Marie Schmidt Erikson, Karin Mogensen, Susanne Rosthøj, Gregers Gautier Hermann. Outpatient Photodynamic Diagnosis-guided Laser Destruction of Bladder Tumors Is as Good as Conventional Inpatient Photodynamic Diagnosis-guided Transurethral Tumor Resection in Patients with Recurrent Intermediate-risk Low-grade Ta Bladder Tumors. A Prospective Randomized Noninferiority Clinical Trial. Eur Urol 2023;83:125-30.

Autor: Pedersen GL; Department of Urology, Herlev-Gentofte Hospital, Capital Region of Denmark, Copenhagen, Denmark. Electronic address: gyrithe.lynghoej.pedersen.01@regionh.dk., Mogensen K; Department of Urology, Herlev-Gentofte Hospital, Capital Region of Denmark, Copenhagen, Denmark., Rosthøj S; Statistics & Data Analysis, Danish Cancer Institute, Strandboulevarden 49, Copenhagen, 2100, Denmark., Hermann GG; Department of Urology, Herlev-Gentofte Hospital, Capital Region of Denmark, Copenhagen, Denmark.

Publikováno v: European urology [Eur Urol] 2023 Dec; Vol. 84 (6), pp. e154. Date of Electronic Publication: 2023 Jul 26.

External Validation of the 2003 Leibovich Prognostic Score in Patients Randomly Assigned to SORCE, an International Phase III Trial of Adjuvant Sorafenib in Renal Cell Cancer.

Autor: Oza B; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, London, United Kingdom., Eisen T; Department of Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom., Frangou E; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, London, United Kingdom., Stewart GD; Department of Surgery, University of Cambridge, Cambridge, United Kingdom., Bex A; Royal Free London NHS Foundation Trust UCL Division of Surgery and Interventional Science, London, United Kingdom.; Netherlands Cancer Institute, Amsterdam, the Netherlands., Ritchie AWS; MRC Clinical Trials Unit Trial, London, United Kingdom., Kaplan R; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, London, United Kingdom., Smith B; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, London, United Kingdom., Davis ID; Department of Medical Oncology, Eastern Health, Melbourne, Australia.; Eastern Health Clinical School, Monash University, Melbourne, Australia.; ANZUP Cancer Trials Group, Sydney, Australia., Stockler MR; ANZUP Cancer Trials Group, Sydney, Australia.; NHMRC Clinical Trials Centre, Medicine, Central Clinical School, Sydney, NSW, Australia., Albiges L; Institut Gustave Roussy, Villejuif, France., Escudier B; Institut Gustave Roussy, Villejuif, France., Larkin J; The Royal Marsden Hospital, NHS Foundation Trust, London, United Kingdom., Joniau S; Department of Development and Regeneration-Urogenital, Abdominal and Plastic Surgery, Leuven, Belgium., Hancock B; University of Sheffield, Sheffield, United Kingdom., Hermann GG; Urology Research Unit, Department of Urology, Herlev, Denmark., Bellmunt J; Beth Israel Deaconess Medical Center-IMIM Research Lab, Boston, MA., Parmar MKB; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, London, United Kingdom., Royston P; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, London, United Kingdom., Meade A; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, London, United Kingdom.

Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2022 Jun 01; Vol. 40 (16), pp. 1772-1782. Date of Electronic Publication: 2022 Feb 25.

An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer.

Autor: Lindskrog SV; Department of Molecular Medicine, Aarhus University Hospital, Aarhus N, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Prip F; Department of Molecular Medicine, Aarhus University Hospital, Aarhus N, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Lamy P; Department of Molecular Medicine, Aarhus University Hospital, Aarhus N, Denmark., Taber A; Department of Molecular Medicine, Aarhus University Hospital, Aarhus N, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Groeneveld CS; Cartes d'Identité des Tumeurs (CIT) Program, Ligue Nationale Contre le Cancer, Paris, France.; Oncologie Moleculaire, UMR144, Institut Curie, Paris, France., Birkenkamp-Demtröder K; Department of Molecular Medicine, Aarhus University Hospital, Aarhus N, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Jensen JB; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.; Department of Urology, Aarhus University Hospital, Aarhus N, Denmark., Strandgaard T; Department of Molecular Medicine, Aarhus University Hospital, Aarhus N, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Nordentoft I; Department of Molecular Medicine, Aarhus University Hospital, Aarhus N, Denmark., Christensen E; Department of Molecular Medicine, Aarhus University Hospital, Aarhus N, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Sokac M; Department of Molecular Medicine, Aarhus University Hospital, Aarhus N, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Birkbak NJ; Department of Molecular Medicine, Aarhus University Hospital, Aarhus N, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Maretty L; Department of Molecular Medicine, Aarhus University Hospital, Aarhus N, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Hermann GG; Department of Urology, Herlev hospital, Copenhagen University, Copenhagen, Denmark., Petersen AC; Department of Pathology, Aalborg University Hospital, Aalborg, Denmark., Weyerer V; Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany., Grimm MO; Department of Urology, Jena University Hospital, Jena, Germany., Horstmann M; Department of Urology, Jena University Hospital, Jena, Germany.; Department of Urology, Malteser Hospital St. Josephshospital, Krefeld Uerdingen, Krefeld, Germany., Sjödahl G; Division of Urological Research, Department of Translational Medicine, Lund University, Skåne University Hospital, Malmö, Sweden., Höglund M; Division of Oncology and Pathology, Department of Clinical Sciences, Lund University, Lund, Sweden., Steiniche T; Department of Pathology, Aarhus University Hospital, Aarhus N, Denmark., Mogensen K; Department of Urology, Herlev hospital, Copenhagen University, Copenhagen, Denmark., de Reyniès A; Cartes d'Identité des Tumeurs (CIT) Program, Ligue Nationale Contre le Cancer, Paris, France., Nawroth R; Department of Urology, Technical University of Munich, Klinikum rechts der Isar, Munich, Germany., Jordan B; Departments of Pathology, Urology, Biochemistry and Molecular Genetics, Northwestern University School of Medicine, Chicago, IL, USA., Lin X; Departments of Pathology, Urology, Biochemistry and Molecular Genetics, Northwestern University School of Medicine, Chicago, IL, USA., Dragicevic D; Clinic of Urology, Clinical Centre of Serbia, Faculty of Medicine, University of Belgrade, Belgrade, Serbia., Ward DG; Bladder Cancer Research Centre, Institute of Cancer and Genomic Sciences, College of Medicine and Dental Sciences, University of Birmingham, Birmingham, UK., Goel A; Bladder Cancer Research Centre, Institute of Cancer and Genomic Sciences, College of Medicine and Dental Sciences, University of Birmingham, Birmingham, UK., Hurst CD; Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, UK., Raman JD; Department of Surgery, Division of Urology, Pennsylvania State University, Hershey, PA, USA., Warrick JI; Department of Pathology and Laboratory Medicine, Division of Urology, Department of Biochemistry and Molecular Biology, Pennsylvania State University, Hershey, PA, USA., Segersten U; Department of Surgical Sciences, Uppsala University, Uppsala, Sweden., Sikic D; Department of Urology and Pediatric Urology, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany., van Kessel KEM; Department of Pathology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., Maurer T; Department of Urology, Technical University of Munich, Klinikum rechts der Isar, Munich, Germany.; Department of Urology and Martini-Clinic, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Meeks JJ; Departments of Pathology, Urology, Biochemistry and Molecular Genetics, Northwestern University School of Medicine, Chicago, IL, USA., DeGraff DJ; Department of Pathology and Laboratory Medicine, Division of Urology, Department of Biochemistry and Molecular Biology, Pennsylvania State University, Hershey, PA, USA., Bryan RT; Bladder Cancer Research Centre, Institute of Cancer and Genomic Sciences, College of Medicine and Dental Sciences, University of Birmingham, Birmingham, UK., Knowles MA; Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, UK., Simic T; Institute of Medical and Clinical Biochemistry, Faculty of Medicine, University of Belgrade, Belgrade, Serbia., Hartmann A; Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany., Zwarthoff EC; Department of Pathology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., Malmström PU; Department of Surgical Sciences, Uppsala University, Uppsala, Sweden., Malats N; Genetic and Molecular Epidemiology Group, Spanish National Cancer Research Center (CNIO), CIBERONC, Madrid, Spain., Real FX; Epithelial Carcinogenesis Group, Spanish National Cancer Research Center (CNIO), Madrid, Spain.; Departament de Ciències Experimentals i de la Salut, Universitat Pompeu Fabra, CIBERONC, Barcelona, Spain., Dyrskjøt L; Department of Molecular Medicine, Aarhus University Hospital, Aarhus N, Denmark. lars@clin.au.dk.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark. lars@clin.au.dk.

Publikováno v: Nature communications [Nat Commun] 2021 Apr 16; Vol. 12 (1), pp. 2301. Date of Electronic Publication: 2021 Apr 16.